호흡기 흡입기 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00003093
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 254
Buy Now

호흡기 흡입기 시장은 2022년 311억 4456만 달러에서 2028년 434억 4619만 달러로 성장할 것으로 예상된다. 2022년부터 2028년까지 연평균 성장률(CAGR) 5.7%를 기록할 것으로 추정됩니다.

호흡기 흡입기는 만성 폐질환 치료에 필수적인 약물을 흡입하는 데 사용됩니다. 이는 이러한 만성 질환의 악화를 예방하고 치료하는 데 사용됩니다. 이는 약물이 폐에 직접 도달하도록 보장하면서 전신 약물 노출을 방지하는 이점을 제공합니다. 건조 분말 흡입기, 정량 흡입기(MDI), 분무기, 연무 흡입기 등 다양한 제품이 기도에 직접 약물을 전달합니다. 호흡기 흡입기 시장은 천식, 만성 폐쇄성 폐질환(COPD), 낭포성 섬유증, 천식-COPD 중복 증후군 등과 같은 호흡기 질환의 유병률 증가로 인해 성장할 것으로 예상됩니다.

전략적 통찰력 

호흡기 흡입기 시장 통찰력

일반 흡입기의 채택 증가로 호흡 흡입기 시장 성장 촉진

다양한 흡입 장치를 사용하는 흡입 의약품은 약리학 분야의 중심입니다. 천식 및 COPD 치료. 천식과 COPD로 고통받는 환자는 기도를 건강하게 유지하기 위해 매일 하나 이상의 흡입기가 필요한 경우가 많습니다. 따라서 의료 전문가들은 에어로졸 전달 장치 유형의 낮은 순응도와 오용을 통해 질병 통제에 부정적인 영향을 미칠 수 있으므로 약물 간 전환에 대해 우려하고 있습니다. 의료 예산에 대한 압박이 증가하고 확립된 흡입 치료법에 대한 특허가 동시에 만료됨에 따라 여러 일반 대체 제품이 전 세계적으로 제조 및 공급되고 있습니다. 천식 치료에 사용되는 여러 흡입제에는 알부테롤, 레발부테롤, 이프라트로피움, 부데소니드 및 플루티카손/살메테롤과 같은 일반 제제가 포함됩니다. 일반 흡입기는 브랜드 버전과 생물학적으로 동일하며 신체에 동일한 효과를 나타냅니다. 특허가 만료됨에 따라 일반 천식 흡입기의 수가 계속 증가하고 있습니다. 2020년 3월 3일, 식품의약국(FDA)은 일반 천식 흡입기와 일반 흡입용 코르티코스테로이드 분말을 허가했습니다. 2020년 4월, FDA는 호흡 곤란을 겪는 코로나19 환자의 요구를 충족하기 위해 알부테롤 황산염 기반 일반 흡입기를 승인했습니다. 더 많은 제네릭 의약품이 시장에 진입함에 따라 경쟁이 심화될 것으로 예상되며, 이는 결국 의약품 비용 감소로 이어진다. 비용 절감은 '승인된 제네릭 의약품'의 출시로 인해 발생할 수도 있습니다. 따라서 일반 흡입기 및 천식 약물의 채택이 증가함에 따라 약물 순응도가 향상되어 호흡기 흡입기 시장이 성장하고 있습니다.

제품 유형 기반 통찰력

제품 유형을 기준으로 호흡기 흡입기 시장은 흡입기 시장은 분무기, 정량 흡입기 및 건조 분말 흡입기로 분류됩니다. 건조 분말 흡입기 부문은 다회 용량 건조 분말 흡입기와 단일 용량 건조 분말 흡입기로 더 분기됩니다. 정량 흡입기(MDI) 세그먼트는 가압 정량 흡입기와 연결된 정량 흡입기로 더 나뉩니다. 분무기 부문은 압축 공기 분무기, 메시 공기 분무기 및 초음파 공기 분무기로 세분화됩니다. 2022년에는 건조 분말 흡입기 부문이 가장 큰 시장 점유율을 차지했습니다. 그러나 정량 흡입기(MDI) 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

제품 유형별 호흡기 흡입기 시장– 2022년 및 2028년

기술 기반 통찰력

기술을 기반으로 하는 호흡 흡입기 시장은 수동으로 작동하는 흡입기와 디지털로 작동하는 흡입기로 나누어집니다. 수동식 흡입기 부문은 2022년에 더 큰 시장 점유율을 차지했으며 예측 기간 동안 더 높은 CAGR을 기록할 것으로 예상됩니다.

질병 징후 기반 통찰력

질병 적응증을 기준으로 전 세계 호흡기 흡입기 시장은 천식, COPD, 폐동맥 고혈압 등으로 분류됩니다. 천식 부문은 2022년 시장에서 가장 큰 점유율을 차지했으며 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.   

인수합병과 같은 무기 및 유기 전략은 호흡기 흡입기 시장의 기업에서 많이 채택하고 있습니다. 최근 몇 가지 주요 시장 발전 상황은 다음과 같습니다.

  • 2022년 9월 Beximco Pharmaceuticals는 건식 흡입기 캡슐인 ONRIVA TRIO BEXICAP을 출시했습니다. ONRIVA TRIO BEXICAP은 Indacaterol(150μg), Glycopyrronium(50μg) 및 Mometasone(160μg)의 제제입니다. 천식 증상을 조절하는 3가지 방법으로 작동합니다. 인다카테롤과 글리코피로니움은 폐 기도 근육을 이완시켜 기관지 수축을 예방하고, 모메타손은 염증을 줄이는 데 도움을 줍니다. ONRIVA TRIO BEXICAP은 중증 지속성 천식의 유지 요법으로 표시됩니다.
  • 2021년 6월 Cipla는 Arformoterol Tartrate 흡입 용액 15mcg/2에 대한 단축 신약 신청(ANDA)에 대한 최종 승인을 받았다고 발표했습니다. 미국 식품의약국(FDA)의 mL. Cipla의 Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL는 Sunovion Pharmaceuticals Inc.의 Brovana와 동등한 AN 등급 일반 치료 버전입니다.
  • 2022년 2월 AstraZeneca와 Honeywell은 개발을 위해 협력할 계획을 발표했습니다. 현재 호흡기 의약품에 사용되는 추진제보다 지구 온난화 지수(GWP)가 최대 99.9% 낮은 추진제 HFO-1234ze를 사용하는 차세대 호흡기 흡입기입니다.
  • 2023년 1월 FDA는 Airsupra [가압식 정량 흡입기(pMDI)]가 기관지 수축의 필요에 따른 치료 또는 예방을 위해 미국에서 출시되었습니다. 에어수프라는 단기 작용 베타2 작용제(SABA)인 알부테롤과 항염증성 흡입 코르티코스테로이드(ICS)인 부데소니드를 함유한 업계 최초의 가압 정량 흡입기(pMDI) 고정 용량 복합 구조 약물입니다. 미국에서.  

회사 프로필   

  • AstraZeneca Plc
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • GSK Plc
  • Koninklijke Philips NV
  • OMRON Corp
  • PARI 호흡기 장비 주식회사
  • Teva Pharmaceutical Industries Ltd.
  • OPKO Health, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the respiratory inhalers market?

Respiratory inhalers are used to inhale drugs that are an essential part of treating chronic lung diseases. They are used both to prevent and treat exacerbations of these chronic diseases. They offer the advantage of avoiding systemic drug exposure while ensuring the drugs reach the lungs directly. Numerous products deliver drugs directly into the airways, such as dry powder inhalers, metered dose inhalers (MDIs), nebulizers and soft mist inhalers. The respiratory inhaler market is expected to flourish due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma-COPD overlap syndrome, and others.

What are the driving factors for the respiratory inhalers market across the globe?

Key factors driving the market growth are rising cases of respiratory disorders and growing adoption of generic inhalers.

Which segment led the respiratory inhalers market?

The respiratory inhalers market, by product type, is segmented into nebulizers, metered dose inhalers, and dry powder inhalers. The dry powder inhalers segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period (2022–2028).

Which technology segment held the largest revenue (US$ Mn) in the respiratory inhalers market?

Based on technology, the global respiratory inhalers market is divided into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.

Who are the key players in the respiratory inhalers market?

Companies operating in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH, Cipla Ltd.;GSK Plc, Koninklijke Philips NV, OMRON Corp, PARI Respiratory Equipment, Inc.; Teva Pharmaceutical Industries Ltd.; and OPKO Health, Inc..

What is the regional market scenario of the respiratory inhalers market?

Global respiratory inhalers market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the respiratory inhalers market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

The List of Companies - Respiratory Inhalers Market

  1. AstraZeneca Plc
  2. Beximco Pharmaceuticals Ltd.
  3. Boehringer Ingelheim International GmbH
  4. Cipla Ltd.
  5. GSK Plc
  6. Koninklijke Philips NV
  7. OMRON Corp
  8. PARI Respiratory Equipment, Inc.
  9. Teva Pharmaceutical Industries Ltd.
  10. OPKO Health, Inc.  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports